M&T Bank
OLMA icon

M&T Bank’s Olema Pharmaceuticals OLMA Stock Holding History

M&T Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,735
Closed -$296K – 1610
2021
Q3 		$296K Buy
+10,735
New +$290K ﹤0.01% 1237
2021
Q1 		– Sell
-5,283
Closed -$254K – 1669
2020
Q4 		$254K Buy
+5,283
New +$248K ﹤0.01% 1401

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

M&T Bank's OLMA Position: Q4 2021 in Review

M&T Bank sold out of Olema Pharmaceuticals (OLMA) in Q4 2021, closing a stake of 10,735 shares — an estimated $296K sold.

M&T Bank first reported a position in OLMA in Q4 2020 and held it in 2 quarters. The position peaked at $296K in Q3 2021. 97 funds tracked by Wall St. Rank hold OLMA as of Q4 2021.

  • M&T Bank reported no remaining Olema Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • M&T Bank sold 10,735 Olema Pharmaceuticals shares in Q4 2021, an estimated $296K.
  • M&T Bank first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • M&T Bank's Olema Pharmaceuticals position peaked at $296K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2021.

Based on M&T Bank's 13F filing for Q4 2021, filed 7 Feb 2022.